ArticleMolecular pain2011

Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain.

Ohannes K Melemedjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.